CHRNA7 anticorps

N° du produit ABIN7190248

Détail du produit anti-CHRNA7 anticorps

Antigène: CHRNA7 (Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CHRNA7 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Réactivité croisée: Humain, Souris, Rat

Purification: Antigen affinity purification

Immunogène: Synthetic peptide of Human CHRFAM7A

Isotype: IgG

Information d'application

Indications d'application: ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur CHRNA7

Antigène: CHRNA7 (Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7))

Autre désignation: CHRNA7 (CHRNA7 Produits)

Synonymes: anticorps CHRNA7-2, anticorps NACHRA7, anticorps dZ70B1.1, anticorps Acra7, anticorps alpha7, anticorps BTX, anticorps NARAD, anticorps nAChRa7, anticorps CHRNA7, anticorps cholinergic receptor nicotinic alpha 7 subunit, anticorps neuronal acetylcholine receptor subunit alpha-7, anticorps cholinergic receptor, nicotinic, alpha 7 (neuronal), anticorps cholinergic receptor, nicotinic, alpha polypeptide 7, anticorps cholinergic receptor, nicotinic, alpha 7, anticorps CHRNA7, anticorps LOC100374356, anticorps chrna7, anticorps Chrna7, anticorps LOC100060521

Sujet:

Background: The nicotinic acetylcholine receptors (nAChRs) are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. The family member CHRNA7, which is located on chromosome 15 in a region associated with several neuropsychiatric disorders, is partially duplicated and forms a hybrid with a novel gene from the family with sequence similarity 7 (FAM7A). Alternative splicing has been observed, and two variants exist, for this hybrid gene. The N-terminally truncated products predicted by the largest open reading frames for each variant would lack the majority of the neurotransmitter-gated ion-channel ligand binding domain but retain the transmembrane region that forms the ion channel. Although current evidence supports transcription of this hybrid gene, translation of the nicotinic acetylcholine receptor-like protein-encoding open reading frames has not been confirmed.

Aliases: 7nAChR antibody, a7 nicotinic acetylcholine receptor antibody, acetylcholine receptor, neuronal nicotinic, alpha-7 subunit antibody, ACHA7_HUMAN antibody, AChR antibody, Acra7 antibody, alpha 7 neuronal nicotinic acetylcholine receptor antibody, alpha-7 nicotinic cholinergic receptor subunit antibody, alpha7 antibody, cholinergic receptor, neuronal nicotinic, alpha polypeptide 7 antibody, cholinergic receptor, nicotinic, alpha 7 (neuronal) antibody, cholinergic receptor, nicotinic, alpha 7 antibody, cholinergic receptor, nicotinic, alpha polypeptide 7 antibody, CHRNA7 antibody, CHRNA7-2 antibody, NACHRA7 antibody, neuronal acetylcholine receptor protein, alpha-7 chain antibody, Neuronal acetylcholine receptor subunit alpha-7 antibody

UniProt: P36544

Pathways: Synaptic Membrane